Can-Fite BioPharma Ltd.
(CANF)
undefined
undefined%
At close: undefined
1.58
-0.32%
After-hours Dec 13, 2024, 07:33 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 4.28M | 2.98M | 4.39M | 8.27M | 2.70M | 3.62M | 3.50M | 8.11M | 16.91M | 9.27M | 5.96M | 1.15M | 3.84M |
| Short-Term Investments | 4.64M | 5.00M | 14.75M | 75.00K | 64.00K | 273.00K | - | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | 912.00K | - | 914.66K | 9.61K | 6.94K | - | - | - | - |
| Other Long-Term Assets | - | -126.00K | -185.00K | -123.00K | - | 2.00K | 5.18K | 5.24 | -23 | 6.68K | 9.76K | - | - |
| Receivables | - | 47.00K | 48.00K | 18.00K | - | - | 66.00K | 21.84K | 619.67K | 69.85K | 57.72K | - | 98.27K |
| Inventory | - | -39.00K | -48.00K | 964.00K | - | -3.97M | -3.30M | - | -559.49K | - | -623.20K | - | 1.00 |
| Other Current Assets | 986.00K | 1.12M | 881.00K | 1.04M | 4.38M | 4.01M | 3.16M | 1.97M | 1.12M | 807.67K | 562.81K | 415.16K | 885.52K |
| Total Current Assets | 9.91M | 9.16M | 20.07M | 9.40M | 7.14M | 7.90M | 6.87M | 10.10M | 17.53M | 10.15M | 6.58M | 1.59M | 4.83M |
| Property-Plant & Equipment | 81.00K | 126.00K | 185.00K | 123.00K | 118.00K | 47.00K | 46.03K | 53.29K | 60.46K | 34.16K | 41.06K | 42.56K | 73.04K |
| Goodwill & Intangibles | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Long-Term Assets | 81.00K | 126.00K | 185.00K | 123.00K | 1.03M | 49.00K | 965.88K | 62.91K | 67.37K | 40.83K | 50.83K | 42.56K | 73.04K |
| Total Assets | 9.99M | 9.28M | 20.25M | 9.52M | 8.17M | 7.95M | 7.83M | 10.17M | 17.60M | 10.19M | 6.63M | 1.64M | 4.90M |
| Account Payables | 427.00K | 896.00K | 954.00K | 561.00K | 2.16M | 1.07M | 427.00K | 1.25M | 461.87K | 262.97K | 590.38K | 756.08K | 507.09K |
| Deferred Revenue | 622.00K | 783.00K | 818.00K | 334.00K | 469.00K | 926.00K | 373.75K | 321.58K | 219.54K | - | - | - | - |
| Short-Term Debt | 27.00K | 96.00K | 106.00K | 86.00K | 72.00K | - | - | - | - | - | - | - | - |
| Other Current Liabilities | 944.00K | 727.00K | 852.00K | 288.00K | 574.00K | 1.12M | 1.33M | 933.69K | 1.10M | 1.22M | 1.56M | 1.57M | 846.03K |
| Total Current Liabilities | 2.02M | 2.50M | 2.73M | 1.27M | 3.27M | 3.12M | 1.80M | 2.50M | 1.78M | 1.48M | 2.14M | 2.32M | 1.35M |
| Long-Term Debt | 13.00K | 14.00K | 71.00K | 24.00K | 39.00K | - | - | - | - | - | - | - | - |
| Other Long-Term Liabilities | - | - | - | - | - | - | 846.00K | 2.62M | 4.45M | 1.85M | 37.04K | 18.20K | 258.28K |
| Total Long-Term Liabilities | 1.73M | 2.31M | 3.14M | 2.18M | 2.46M | 1.82M | 2.98M | 3.79M | 5.38M | 1.85M | 37.04K | 18.20K | 258.28K |
| Total Liabilities | 3.75M | 4.81M | 5.87M | 3.45M | 5.73M | 4.94M | 4.78M | 6.29M | 7.16M | 3.33M | 2.18M | 2.34M | 1.61M |
| Total Debt | 40.00K | 62.00K | 124.00K | 67.00K | 75.00K | - | - | - | - | - | - | - | - |
| Common Stock | - | - | 60.65M | 33.04M | 8.22M | 2.63M | 2.39M | 1.83M | 1.80M | 1.40M | 1.16M | 731.81K | 684.71K |
| Retained Earnings | -158.48M | -150.85M | -140.67M | -125.47M | -110.31M | -100.62M | -105.66M | -90.98M | -82.71M | -78.11M | -80.51M | -67.28M | -60.85M |
| Comprehensive Income | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 6.93M | 6.28M | 5.08M | 4.58M | 4.14M | 4.48M | 4.11M | 3.87M |
| Shareholders Equity | 6.24M | 4.47M | 14.38M | 6.07M | 2.44M | 3.02M | 3.05M | 3.87M | 10.32M | 6.48M | 3.80M | -1.24M | 2.71M |
| Total Investments | 4.64M | 5.00M | 14.75M | 75.00K | 64.00K | 273.00K | 914.66K | 9.61K | 6.94K | - | - | - | - |